Evaluation of a transdermal buprenorphine formulation in opioid detoxification.

Evaluation of a transdermal buprenorphine formulation in opioid detoxification.

Item
http://www.wikidata.org/entity/Q39330460
Buprenorphine for the management of opioid withdrawalOpioid Addiction: Social Problems Associated and Implications of Both Current and Possible Future Treatments, including Polymeric Therapeutics for Giving Up the Habit of Opioid Consumption.Carbon Nanotube Membranes for use in the Transdermal Treatment of Nicotine Addiction and Opioid Withdrawal Symptoms.Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.A novel approach in the detoxification of intravenous buprenorphine dependence.Probuphine® (buprenorphine implant): a promising candidate in opioid dependence.Buprenorphine for managing opioid withdrawal.Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.Transdermal patches: the emerging mode of drug delivery system in psychiatry.Advances in the delivery of buprenorphine for opioid dependence.Rewarding or aversive effects of buprenorphine/naloxone combination (Suboxone) depend on conditioning trial duration.
P2860

Evaluation of a transdermal buprenorphine formulation in opioid detoxification.

Item
http://www.wikidata.org/entity/Q39330460
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
@en
Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
@nl
type
label
Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
@en
Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
@nl
prefLabel
Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
@en
Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1360-0443.2007.01944.X
P407
P433
P478
P577
P698
P921